Stryker Corporation Logo

Stryker Corporation

SYK.DE

(2.5)
Stock Price

210,60 EUR

17.2% ROA

18.41% ROE

26.43x PER

Market Cap.

87.417.955.939,93 EUR

67.1% DER

0% Yield

16.03% NPM

Stryker Corporation Stock Analysis

Stryker Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Stryker Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (15.03%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

3 Assets Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

4 DER

The stock has a reasonable amount of debt compared to its ownership (58%), suggesting a balanced financial position and a moderate level of risk.

5 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

6 Net Profit Growth

The net profit of this company has shown steady growth over the past three years, highlighting its positive financial trajectory and making it an appealing choice for potential investors.

7 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (1.414) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

8 PBV

The stock's elevated P/BV ratio (4.86x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

9 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

10 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

11 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

Stryker Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Stryker Corporation Technical Stock Analysis
# Analysis Recommendation

Stryker Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Stryker Corporation Revenue
Year Revenue Growth
1985 101.600.000
1986 121.100.000 16.1%
1987 148.100.000 18.23%
1988 178.600.000 17.08%
1989 225.900.000 20.94%
1990 280.600.000 19.49%
1991 364.800.000 23.08%
1992 477.100.000 23.54%
1993 557.300.000 14.39%
1994 681.900.000 18.27%
1995 872.000.000 21.8%
1996 910.100.000 4.19%
1997 980.100.000 7.14%
1998 1.103.200.000 11.16%
1999 2.103.700.000 47.56%
2000 2.289.400.000 8.11%
2001 2.602.300.000 12.02%
2002 3.011.600.000 13.59%
2003 3.625.300.000 16.93%
2004 4.262.300.000 14.94%
2005 4.871.500.000 12.51%
2006 5.405.600.000 9.88%
2007 6.000.500.000 9.91%
2008 6.718.200.000 10.68%
2009 6.723.100.000 0.07%
2010 7.320.000.000 8.15%
2011 8.307.000.000 11.88%
2012 8.657.000.000 4.04%
2013 9.021.000.000 4.04%
2014 9.675.000.000 6.76%
2015 9.946.000.000 2.72%
2016 11.325.000.000 12.18%
2017 12.444.000.000 8.99%
2018 13.601.000.000 8.51%
2019 14.884.000.000 8.62%
2020 14.351.000.000 -3.71%
2021 17.108.000.000 16.12%
2022 18.449.000.000 7.27%
2023 19.636.000.000 6.05%
2023 20.498.000.000 4.21%
2024 20.972.000.000 2.26%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Stryker Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 39.600.000 100%
1995 43.800.000 9.59%
1996 56.900.000 23.02%
1997 56.900.000 0%
1998 61.100.000 6.87%
1999 105.200.000 41.92%
2000 122.200.000 13.91%
2001 142.100.000 14%
2002 141.400.000 -0.5%
2003 180.200.000 21.53%
2004 211.000.000 14.6%
2005 279.800.000 24.59%
2006 324.600.000 13.8%
2007 375.300.000 13.51%
2008 367.800.000 -2.04%
2009 336.200.000 -9.4%
2010 393.900.000 14.65%
2011 462.000.000 14.74%
2012 471.000.000 1.91%
2013 536.000.000 12.13%
2014 614.000.000 12.7%
2015 625.000.000 1.76%
2016 715.000.000 12.59%
2017 787.000.000 9.15%
2018 862.000.000 8.7%
2019 971.000.000 11.23%
2020 984.000.000 1.32%
2021 1.235.000.000 20.32%
2022 1.454.000.000 15.06%
2023 1.412.000.000 -2.97%
2023 1.388.000.000 -1.73%
2024 1.472.000.000 5.71%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Stryker Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 5.099.000.000 100%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Stryker Corporation EBITDA
Year EBITDA Growth
1985 16.700.000
1986 21.500.000 22.33%
1987 25.700.000 16.34%
1988 32.800.000 21.65%
1989 38.600.000 15.03%
1990 40.400.000 4.46%
1991 61.500.000 34.31%
1992 81.900.000 24.91%
1993 104.000.000 21.25%
1994 134.300.000 22.56%
1995 180.200.000 25.47%
1996 142.700.000 -26.28%
1997 206.700.000 30.96%
1998 355.300.000 41.82%
1999 739.800.000 51.97%
2000 600.500.000 -23.2%
2001 643.600.000 6.7%
2002 768.500.000 16.25%
2003 897.200.000 14.34%
2004 1.209.500.000 25.82%
2005 1.316.000.000 8.09%
2006 1.482.000.000 11.2%
2007 1.630.900.000 9.13%
2008 1.915.200.000 14.84%
2009 2.084.200.000 8.11%
2010 2.430.400.000 14.24%
2011 2.319.000.000 -4.8%
2012 2.377.000.000 2.44%
2013 1.659.000.000 -43.28%
2014 1.624.000.000 -2.16%
2015 2.850.000.000 43.02%
2016 3.028.000.000 5.88%
2017 3.278.000.000 7.63%
2018 3.079.000.000 -6.46%
2019 3.875.000.000 20.54%
2020 3.069.000.000 -26.26%
2021 3.780.000.000 18.81%
2022 4.241.000.000 10.87%
2023 4.844.000.000 12.45%
2023 4.952.000.000 2.18%
2024 4.928.000.000 -0.49%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Stryker Corporation Gross Profit
Year Gross Profit Growth
1985 54.200.000
1986 65.000.000 16.62%
1987 80.900.000 19.65%
1988 99.600.000 18.78%
1989 125.300.000 20.51%
1990 154.800.000 19.06%
1991 204.100.000 24.15%
1992 266.800.000 23.5%
1993 316.700.000 15.76%
1994 402.400.000 21.3%
1995 531.200.000 24.25%
1996 552.400.000 3.84%
1997 615.600.000 10.27%
1998 668.700.000 7.94%
1999 1.380.000.000 51.54%
2000 1.548.900.000 10.9%
2001 1.638.500.000 5.47%
2002 1.900.400.000 13.78%
2003 2.312.900.000 17.83%
2004 2.752.200.000 15.96%
2005 3.157.600.000 12.84%
2006 3.556.900.000 11.23%
2007 4.135.300.000 13.99%
2008 4.586.800.000 9.84%
2009 4.539.400.000 -1.04%
2010 5.034.300.000 9.83%
2011 5.496.000.000 8.4%
2012 5.876.000.000 6.47%
2013 6.044.000.000 2.78%
2014 6.384.000.000 5.33%
2015 6.602.000.000 3.3%
2016 7.495.000.000 11.91%
2017 8.173.000.000 8.3%
2018 8.938.000.000 8.56%
2019 9.696.000.000 7.82%
2020 9.057.000.000 -7.06%
2021 10.968.000.000 17.42%
2022 11.578.000.000 5.27%
2023 12.632.000.000 8.34%
2023 13.058.000.000 3.26%
2024 13.332.000.000 2.06%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Stryker Corporation Net Profit
Year Net Profit Growth
1985 8.400.000
1986 10.100.000 16.83%
1987 12.700.000 20.47%
1988 15.900.000 20.13%
1989 19.200.000 17.19%
1990 23.600.000 18.64%
1991 33.100.000 28.7%
1992 47.700.000 30.61%
1993 60.200.000 20.76%
1994 72.400.000 16.85%
1995 87.000.000 16.78%
1996 104.500.000 16.75%
1997 125.300.000 16.6%
1998 39.600.000 -216.41%
1999 19.400.000 -104.12%
2000 221.000.000 91.22%
2001 267.000.000 17.23%
2002 345.600.000 22.74%
2003 453.500.000 23.79%
2004 465.700.000 2.62%
2005 675.200.000 31.03%
2006 777.700.000 13.18%
2007 1.017.400.000 23.56%
2008 1.147.800.000 11.36%
2009 1.107.400.000 -3.65%
2010 1.273.400.000 13.04%
2011 1.345.000.000 5.32%
2012 1.298.000.000 -3.62%
2013 1.006.000.000 -29.03%
2014 515.000.000 -95.34%
2015 1.439.000.000 64.21%
2016 1.647.000.000 12.63%
2017 1.020.000.000 -61.47%
2018 3.553.000.000 71.29%
2019 2.083.000.000 -70.57%
2020 1.599.000.000 -30.27%
2021 1.994.000.000 19.81%
2022 2.358.000.000 15.44%
2023 2.768.000.000 14.81%
2023 3.165.000.000 12.54%
2024 3.152.000.000 -0.41%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Stryker Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 1 0%
2001 1 0%
2002 1 0%
2003 1 100%
2004 1 0%
2005 2 0%
2006 2 0%
2007 2 50%
2008 3 0%
2009 3 0%
2010 3 33.33%
2011 3 0%
2012 3 0%
2013 3 -50%
2014 1 -100%
2015 4 66.67%
2016 4 25%
2017 3 -100%
2018 10 77.78%
2019 6 -80%
2020 4 -25%
2021 5 20%
2022 6 16.67%
2023 0 0%
2023 8 100%
2024 8 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Stryker Corporation Free Cashflow
Year Free Cashflow Growth
1989 14.400.000
1990 35.200.000 59.09%
1991 21.000.000 -67.62%
1992 19.100.000 -9.95%
1993 31.300.000 38.98%
1994 68.500.000 54.31%
1995 75.200.000 8.91%
1996 177.600.000 57.66%
1997 56.700.000 -213.23%
1998 -1.591.400.000 103.56%
1999 207.800.000 865.83%
2000 251.100.000 17.24%
2001 306.400.000 18.05%
2002 364.900.000 16.03%
2003 504.000.000 27.6%
2004 405.500.000 -24.29%
2005 592.100.000 31.51%
2006 649.800.000 8.88%
2007 840.600.000 22.7%
2008 1.020.700.000 17.64%
2009 1.329.400.000 23.22%
2010 1.365.300.000 2.63%
2011 1.208.000.000 -13.02%
2012 1.447.000.000 16.52%
2013 1.691.000.000 14.43%
2014 1.549.000.000 -9.17%
2015 629.000.000 -146.26%
2016 1.322.000.000 52.42%
2017 961.000.000 -37.57%
2018 2.038.000.000 52.85%
2019 1.542.000.000 -32.17%
2020 2.790.000.000 44.73%
2021 2.738.000.000 -1.9%
2022 2.036.000.000 -34.48%
2023 3.136.000.000 35.08%
2023 902.000.000 -247.67%
2024 37.000.000 -2337.84%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Stryker Corporation Operating Cashflow
Year Operating Cashflow Growth
1989 21.500.000
1990 48.300.000 55.49%
1991 37.600.000 -28.46%
1992 50.700.000 25.84%
1993 86.100.000 41.11%
1994 97.700.000 11.87%
1995 111.500.000 12.38%
1996 204.300.000 45.42%
1997 91.900.000 -122.31%
1998 154.500.000 40.52%
1999 284.000.000 45.6%
2000 331.800.000 14.41%
2001 468.300.000 29.15%
2002 503.900.000 7.06%
2003 648.500.000 22.3%
2004 593.300.000 -9.3%
2005 863.800.000 31.32%
2006 867.300.000 0.4%
2007 1.028.300.000 15.66%
2008 1.175.900.000 12.55%
2009 1.460.700.000 19.5%
2010 1.547.400.000 5.6%
2011 1.434.000.000 -7.91%
2012 1.657.000.000 13.46%
2013 1.886.000.000 12.14%
2014 1.782.000.000 -5.84%
2015 899.000.000 -98.22%
2016 1.812.000.000 50.39%
2017 1.559.000.000 -16.23%
2018 2.610.000.000 40.27%
2019 2.191.000.000 -19.12%
2020 3.277.000.000 33.14%
2021 3.263.000.000 -0.43%
2022 2.624.000.000 -24.35%
2023 3.711.000.000 29.29%
2023 1.050.000.000 -253.43%
2024 204.000.000 -414.71%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Stryker Corporation Capital Expenditure
Year Capital Expenditure Growth
1989 7.100.000
1990 13.100.000 45.8%
1991 16.600.000 21.08%
1992 31.600.000 47.47%
1993 54.800.000 42.34%
1994 29.200.000 -87.67%
1995 36.300.000 19.56%
1996 26.700.000 -35.96%
1997 35.200.000 24.15%
1998 1.745.900.000 97.98%
1999 76.200.000 -2191.21%
2000 80.700.000 5.58%
2001 161.900.000 50.15%
2002 139.000.000 -16.47%
2003 144.500.000 3.81%
2004 187.800.000 23.06%
2005 271.700.000 30.88%
2006 217.500.000 -24.92%
2007 187.700.000 -15.88%
2008 155.200.000 -20.94%
2009 131.300.000 -18.2%
2010 182.100.000 27.9%
2011 226.000.000 19.42%
2012 210.000.000 -7.62%
2013 195.000.000 -7.69%
2014 233.000.000 16.31%
2015 270.000.000 13.7%
2016 490.000.000 44.9%
2017 598.000.000 18.06%
2018 572.000.000 -4.55%
2019 649.000.000 11.86%
2020 487.000.000 -33.26%
2021 525.000.000 7.24%
2022 588.000.000 10.71%
2023 575.000.000 -2.26%
2023 148.000.000 -288.51%
2024 167.000.000 11.38%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Stryker Corporation Equity
Year Equity Growth
1985 48.500.000
1986 59.700.000 18.76%
1987 75.200.000 20.61%
1988 91.000.000 17.36%
1989 112.000.000 18.75%
1990 147.900.000 24.27%
1991 179.900.000 17.79%
1992 232.300.000 22.56%
1993 288.400.000 19.45%
1994 458.300.000 37.07%
1995 559.300.000 18.06%
1996 616.300.000 9.25%
1997 648.500.000 4.97%
1998 668.800.000 3.04%
1999 671.500.000 0.4%
2000 854.900.000 21.45%
2001 1.056.200.000 19.06%
2002 1.498.200.000 29.5%
2003 2.154.800.000 30.47%
2004 2.752.000.000 21.7%
2005 3.251.800.000 15.37%
2006 4.191.000.000 22.41%
2007 5.378.500.000 22.08%
2008 5.406.700.000 0.52%
2009 6.595.100.000 18.02%
2010 7.173.600.000 8.06%
2011 7.683.000.000 6.63%
2012 8.597.000.000 10.63%
2013 9.047.000.000 4.97%
2014 8.596.000.000 -5.25%
2015 8.511.000.000 -1%
2016 9.550.000.000 10.88%
2017 10.008.000.000 4.58%
2018 11.730.000.000 14.68%
2019 12.807.000.000 8.41%
2020 13.084.000.000 2.12%
2021 14.877.000.000 12.05%
2022 16.616.000.000 10.47%
2023 18.593.000.000 10.63%
2023 17.905.000.000 -3.84%
2024 19.172.000.000 6.61%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Stryker Corporation Assets
Year Assets Growth
1985 70.700.000
1986 86.000.000 17.79%
1987 105.000.000 18.1%
1988 124.800.000 15.87%
1989 152.300.000 18.06%
1990 209.500.000 27.3%
1991 270.300.000 22.49%
1992 340.300.000 20.57%
1993 454.200.000 25.08%
1994 768.000.000 40.86%
1995 854.900.000 10.16%
1996 993.500.000 13.95%
1997 985.100.000 -0.85%
1998 2.885.900.000 65.87%
1999 2.580.500.000 -11.83%
2000 2.430.800.000 -6.16%
2001 2.423.600.000 -0.3%
2002 2.815.500.000 13.92%
2003 3.159.100.000 10.88%
2004 4.083.800.000 22.64%
2005 4.944.100.000 17.4%
2006 5.873.800.000 15.83%
2007 7.354.000.000 20.13%
2008 7.603.300.000 3.28%
2009 9.071.300.000 16.18%
2010 10.895.100.000 16.74%
2011 12.405.000.000 12.17%
2012 13.467.000.000 7.89%
2013 15.743.000.000 14.46%
2014 17.713.000.000 11.12%
2015 16.247.000.000 -9.02%
2016 20.435.000.000 20.49%
2017 22.183.000.000 7.88%
2018 27.229.000.000 18.53%
2019 30.167.000.000 9.74%
2020 34.330.000.000 12.13%
2021 34.631.000.000 0.87%
2022 36.884.000.000 6.11%
2023 39.912.000.000 7.59%
2023 38.042.000.000 -4.92%
2024 39.402.000.000 3.45%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Stryker Corporation Liabilities
Year Liabilities Growth
1985 22.200.000
1986 26.300.000 15.59%
1987 29.800.000 11.74%
1988 33.800.000 11.83%
1989 40.300.000 16.13%
1990 61.600.000 34.58%
1991 90.400.000 31.86%
1992 108.000.000 16.3%
1993 165.800.000 34.86%
1994 309.700.000 46.46%
1995 295.600.000 -4.77%
1996 377.200.000 21.63%
1997 336.600.000 -12.06%
1998 2.217.100.000 84.82%
1999 1.909.000.000 -16.14%
2000 1.575.900.000 -21.14%
2001 1.367.400.000 -15.25%
2002 1.317.300.000 -3.8%
2003 1.004.300.000 -31.17%
2004 1.331.800.000 24.59%
2005 1.692.300.000 21.3%
2006 1.682.800.000 -0.56%
2007 1.975.500.000 14.82%
2008 2.196.600.000 10.07%
2009 2.476.200.000 11.29%
2010 3.721.500.000 33.46%
2011 4.722.000.000 21.19%
2012 4.870.000.000 3.04%
2013 6.696.000.000 27.27%
2014 9.117.000.000 26.55%
2015 7.736.000.000 -17.85%
2016 10.885.000.000 28.93%
2017 12.189.000.000 10.7%
2018 15.499.000.000 21.36%
2019 17.360.000.000 10.72%
2020 21.246.000.000 18.29%
2021 19.754.000.000 -7.55%
2022 20.268.000.000 2.54%
2023 21.319.000.000 4.93%
2023 20.137.000.000 -5.87%
2024 20.230.000.000 0.46%

Stryker Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
54.54
Net Income per Share
8.74
Price to Earning Ratio
26.43x
Price To Sales Ratio
4.17x
POCF Ratio
25.6
PFCF Ratio
30.59
Price to Book Ratio
4.63
EV to Sales
4.67
EV Over EBITDA
18.87
EV to Operating CashFlow
28.23
EV to FreeCashFlow
34.27
Earnings Yield
0.04
FreeCashFlow Yield
0.03
Market Cap
87,42 Bil.
Enterprise Value
97,95 Bil.
Graham Number
99.06
Graham NetNet
-33.05

Income Statement Metrics

Net Income per Share
8.74
Income Quality
1.03
ROE
0.18
Return On Assets
0.09
Return On Capital Employed
0.13
Net Income per EBT
0.86
EBT Per Ebit
0.95
Ebit per Revenue
0.2
Effective Tax Rate
0.14

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.07
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.64
Operating Profit Margin
0.2
Pretax Profit Margin
0.19
Net Profit Margin
0.16

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0.34
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
9.03
Free CashFlow per Share
7.44
Capex to Operating CashFlow
-0.18
Capex to Revenue
-0.03
Capex to Depreciation
-0.59
Return on Invested Capital
0.11
Return on Tangible Assets
0.17
Days Sales Outstanding
60.47
Days Payables Outstanding
59.94
Days of Inventory on Hand
241.76
Receivables Turnover
6.04
Payables Turnover
6.09
Inventory Turnover
1.51
Capex per Share
-1.59

Balance Sheet

Cash per Share
6,26
Book Value per Share
49,88
Tangible Book Value per Share
-1.79
Shareholders Equity per Share
49.88
Interest Debt per Share
33.47
Debt to Equity
0.67
Debt to Assets
0.33
Net Debt to EBITDA
2.03
Current Ratio
1.71
Tangible Asset Value
-0,69 Bil.
Net Current Asset Value
-8,34 Bil.
Invested Capital
0.67
Working Capital
4,94 Bil.
Intangibles to Total Assets
0.5
Average Receivables
3,62 Bil.
Average Payables
1,38 Bil.
Average Inventory
4934500000
Debt to Market Cap
0.15

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Stryker Corporation Dividends
Year Dividends Growth
2007 0
2008 0 0%
2009 0 0%
2010 1 0%
2011 1 0%
2012 1 0%
2013 1 100%
2014 1 0%
2015 1 0%
2016 2 0%
2017 2 0%
2018 0 0%
2019 1 0%
2020 2 100%
2021 3 0%
2022 2 0%

Stryker Corporation Profile

About Stryker Corporation

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

CEO
Mr. Kevin A. Lobo
Employee
52.000
Address
2825 Airview Boulevard
Kalamazoo, 49002

Stryker Corporation Executives & BODs

Stryker Corporation Executives & BODs
# Name Age
1 Mr. Spencer S. Stiles
Group President of Orthopaedics & Spine
70
2 Mr. Jason Beach
Vice President of Finance & Investor Relations
70
3 Mr. J. Andrew Pierce
Group President of MedSurg & Neurotechnology
70
4 Mr. Kevin A. Lobo
Chairman, Chief Executive Officer & President
70
5 Mr. William E. Berry Jr.
Vice President & Chief Accounting Officer
70
6 Mr. Alan Douville
Vice President, Chief Information Officer & Chief Information Security Officer
70
7 Mr. Glenn S. Boehnlein
Vice President & Chief Financial Officer
70
8 Mr. Robert C. Cohen
Chief Technology Officer and Vice President of Global R&D - Joint Replacement
70
9 Mr. Robert S. Fletcher
Vice President & Chief Legal Officer
70
10 Mr. Viju S. Menon
Group President of Global Quality & Operations
70

Stryker Corporation Competitors